¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö : 2024-01-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö : 2024-01-27
±³À°ÀÏÀÚ : 2024-01-27
±³À°Àå¼Ò : ½Ã±×´Ï¿¤ ºÎ»ê, 4Ãþ ±×·£µåº¼·ë

±³À°ÁÖÁ¦ : 2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽɺÎÀüÇÐȸ

´ã´çÀÚ : ¹èÀ翬
¿¬¶ôó : 02-3275-5335

À̸ÞÀÏ : kshf3@kshf.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í - »çÀüµî·Ï : Àü¹®ÀÇ(30,000¿ø) / ÀüÀÓÀÇ, ÀÓ»ó°­»ç(10,000¿ø) / Àü°øÀÇ, °£È£»ç, Á¦¾à»ç ±× ¿Ü ÀÇ·áÁ¾»çÀÚ ¹«·á - ÇöÀåµî·Ï: Àü¹®ÀÇ(50,000¿ø) / ÀüÀÓÀÇ, ÀÓ»ó°­»ç(20,000¿ø) / Àü°øÀÇ, °£È£»ç, Á¦¾à»ç ±× ¿Ü ÀÇ·áÁ¾»çÀÚ(10,000¿ø)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:10~10:30 QUEST Trial - Is Qiliqiangxin Really Benefit for Patients? À̼±±â(°í·ÁÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:30~10:50 New Hope for HF? New Era of Anti-obesity Drug ÀÌ»ó¾ð(¿ï»êÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 10:50~11:10 Aldose Reductase Inhibition in Heart Failure ÀÌÂùÁÖ(¿¬¼¼ÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 11:10~11:30 Discussion ±è¹ÌÁ¤ / ¹ÚÁøÁÖ / ¹ÚÈÆÁØ / À§Áø / Àå¼¼¿ë / Á¶ÇöÀç(°¡Å縯ÀÇ´ë / ¼­¿ïÀÇ´ë / °¡Å縯ÀÇ´ë / °¡ÃµÀÇ´ë / °æºÏÀÇ´ë / ¼­¿ïÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 11:30~12:00 Translational Research in Heart Failure Naoki Mochizuki(NCVC, Japan)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 12:00~12:10 Discussion ¹ÚÈÆÁØ / ¿ÀÀç¿ø / ÇÑÁø(°¡Å縯ÀÇ´ë / ¿¬¼¼ÀÇ´ë / ÀÎÁ¦ÀÇ´ë)

½Ä»ç 01¿ù 27ÀÏ ±×·£µåº¼·ë 12:10~13:10 Lunch ()

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:10~13:30 Why PH & RV is Important in HF? Á¤¿íÁø(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:30~13:50 How to Evaluate PH & RV? ÀÌÁÖÈñ(ÃæºÏÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 13:50~14:10 Treatment Options for PH & RV À±Á¾Âù(°¡Å縯ÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 14:10~14:30 Discussion ¹Ú»ó¹Î / ¹è´ëȯ / ½Å¼ºÈñ / À念¿ì / ÃÖÀÇ¿µ(À»ÁöÀÇ´ë / ÃæºÏÀÇ´ë / ÀÎÇÏÀÇ´ë / °¡ÃµÀÇ´ë / ¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 14:30~15:00 Cardiomyopathy : Basic-Clinical-Translational Research °­¼®¹Î(¿¬¼¼ÀÇ´ë)

ÈÞ½Ä 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:00~15:20 Break ()

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:20~15:40 Treatment of HCM Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 15:40~16:00 Fabry Disease: What Needs to Know? ±èÁöÈñ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:00~16:20 Cardiac Amyloidosis Treatment: Now and Next Weapons ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:20~16:40 Discussion ±è´Ù·¡ / ±è¹Ì³ª / ¼­¼®¹Î / Á¶»óÈ£ / ÃÖÁ¤Çö / Ȳ°æ±¹(¼º±Õ°üÀÇ´ë / °í·ÁÀÇ´ë / °¡Å縯ÀÇ´ë / ÇѸ²ÀÇ´ë / ºÎ»êÀÇ´ë / ÃæºÏÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 16:40~17:00 How to Diagnose and Treat in My View À±¹ÎÀç(¼­¿ïÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:00~17:10 Discussion ±è¹Î¼® / ±èÀÀÁÖ / ¹Ú¼º¹Ì / ¼­Áö¿ø / ½ÉÁö¿µ / Á¶µ¿Çõ / ÃÖ°­¿î / ÃÖ¼ºÈÆ(¿ï»êÀÇ´ë / °í·ÁÀÇ´ë / °í·ÁÀÇ´ë / ¿¬¼¼ÀÇ´ë / ¿¬¼¼ÀÇ´ë / °í·ÁÀÇ´ë / ¿µ³²ÀÇ´ë / ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:10~17:30 How to Diagnose and Treat in My View ÇÏ°æÀº(°¡ÃµÀÇ´ë)

Åä·Ð 01¿ù 27ÀÏ ±×·£µåº¼·ë 17:30~17:40 Discussion ±è°èÈÆ / ±èÇüÀ± / ¹ÚÀçÇü / ¾çÅÂÀÏ / À̼ö¿ë / Àü°æÇö / ÇöÁØÈ£ / Ȳ¼®Àç(Àü³²ÀÇ´ë / Àü³²ÀÇ´ë / Ãæ³²ÀÇ´ë / °¡ÃµÀÇ´ë / ºÎ»êÀÇ´ë / ±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø / ¿ï»êÀÇ´ë / °æ»óÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 ´ëÇѽɺÎÀüÇÐȸ µ¿°è½ÉÆ÷Áö¾ö : 2024-01-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѵÎÅëÇÐȸ 2024³â 1¿ù Mini-Symposium : 2024-01-27
´ÙÀ½±Û ºÐ´ç¼­¿ï´ëÇб³º´¿ø 13ȸ COSMOS ½ÉÆ÷Áö¿ò : 2024-01-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 73 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 40 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 48 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 54 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 44 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 44 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 21 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 18 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 46 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 22 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 18 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 45 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 31 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 33 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 28 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷